Instructor in Medicine, Brigham and Women's Hospital
Cardiology
Dr. Michelle L. O'Donoghue, MD
|
|
Give Review
Doctor Michelle L. O'Donoghue, MD practices Cardiology. She researched medicine at Columbia University College of Physicians & Surgeons. Columbia University College of Physicians & Surgeons is a top medical college. Columbia University College of Physicians & Surgeons has a rank of 8 in research and a 52 in primary care She over the years received 1 awards: "Fellow (FACC)". Michelle O'Donoghue is a published doctor as well. She has 42 publications published. The latest was: Women and Heart Attacks.
Publications
- Edoxaban vs. warfarin in vitamin K antagonist experienced and naive patients with Atrial fibrillationâ
- Coronary Stent Thrombosis With Vorapaxar Versus Placebo: Results From the TRA 2°P-TIMI 50 Trial.
- Effect of darapladib on major coronary events after an Acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.
- Acute coronary syndromes: Targeting inflammation-what has the VISTA-16 trial taught us?
- Lipoprotein(a) for Risk Assessment in Patients With Established Coronary Artery Disease.
- Antithrombotic treatment in transcatheter Aortic valve implantation: insights for cerebrovascular and bleeding events.
- Erratum to: Evaluation of the diagnostic performance of Heart-type fatty acid binding protein in the BWH-TIMI ED chest pain study.
- Biomarkers in ACS and Heart Failure: Should Men and Women Be Interpreted Differently?
- Concomitant Administration of Clopidogrel With Statins or Calcium Channel Blockers: Insights From the TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcom...
- Evaluation of the diagnostic performance of Heart-type fatty acid binding protein in the BWH-TIMI ED chest pain study.
- Galectin-3 in cardiovascular Disease: a possible window into early myocardial fibrosis.
- An Invasive or Conservative Strategy in Patients With Diabetes Mellitus and Non-ST-Segment Elevation Acute Coronary Syndromes: A Collaborative Meta-Analysis of Randomi...
- Atopaxar and its effects on markers of platelet activation and inflammation: results from the LANCELOT CAD program.
- Study design and rationale for the Stabilization of pLaques usIng Darapladib-Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an Acute cor...
- Prognostic utility of secretory phospholipase A2 in patients with stable Coronary artery disease.
- Impact of smoking on antiplatelet effect of clopidogrel and prasugrel after loading dose and on maintenance therapy.
- CYP2C19 genotype and proton pump inhibitors in clopidogrel-treated patients: does it take two to tango?
- Clinical uncertainty, diagnostic accuracy, and outcomes in emergency department patients presenting with dyspnea.
- The skinny on fatty acid-binding protein.
- Natriuretic peptides in Heart failure: should therapy be guided by BNP levels?
- Appropriate invasive and conservative treatment approaches for patients with ST-elevation MI.
- Association between baseline neutrophil count, clopidogrel therapy, and clinical and angiographic outcomes in patients with ST-elevation Myocardial infarction receivin...
- N-terminal proBNP: a novel biomarker for the diagnosis, risk stratification and management of congestive Heart failure.
- The future of biomarkers in the management of patients with Acute coronary syndromes.
- Early invasive vs conservative treatment strategies in women and men with unstable Angina and non-ST-segment elevation myocardial infarction: a meta-analysis.
- Soluble ST2 plasma concentrations predict 1-year mortality in Acutely dyspneic emergency department patients with pulmonary disease.
- Measurement of the interleukin family member ST2 in patients with Acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the ...
- Clopidogrel response variability and future therapies: clopidogrel: does one size fit all?
- The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with Acute coronary syndromes undergoing percutaneous intervention:...
- Usefulness of aminoterminal pro-brain natriuretic peptide testing for the diagnostic and prognostic evaluation of dyspneic patients with diabetes mellitus seen in the ...
- Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable Coronary artery disease.
- The effects of ejection fraction on N-terminal ProBNP and BNP levels in patients with Acute CHF: analysis from the ProBNP Investigation of Dyspnea in the Emergency Dep...
- Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without Acute heart failure: results f...
- Prognostic utility of heart-type fatty acid binding protein in patients with Acute coronary syndromes.
- Lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with Acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin...
- Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department.
- Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous Coronary intervention: the Prasugrel in Comparison to Clop...
- Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials.
- Safety and tolerability of atopaxar in the treatment of patients with Acute coronary syndromes: the lessons from antagonizing the cellular effects of ThrombinâAcute Co...
- Randomized trial of atopaxar in the treatment of patients with Coronary artery disease: the lessons from antagonizing the cellular effect of ThrombinâCoronary Artery D...
- Women and Heart Attacks.
Schools
Columbia University College of Physicians And Surgeons
Ma Gen Hospital
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Automatic Implantable Cardioverter Defibrillator (ICD) Implantation
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Fellow (FACC)
Education
-
Massachusetts General Hospital -
Columbia University College of Physicians & Surgeons
Hospital
-
Massachusetts General Hospital -
Brigham and Women's Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1326085366 |
| Last Name Of The Provider | O'DONOGHUE |
| First Name Of The Provider | MICHELLE |
| View All |
Similar Doctors
|
|
Dr. Amil M. Shah, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Hicham Skali Lami, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan D. Brown, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amjad Almahameed, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ik-Kyung Jang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David J. Milan, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. William G. Stevenson, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Lauren E. Frost, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Naomi M. Hamburg, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|